ocrelizumab
SpainDrugs containing this active substance
-
It is used to treat adults with relapsing forms of multiple sclerosis (RMS) and early primary progressive multiple sclerosis (PPMS).
Form: solution for infusion, concentrate
Active substance Dosage ocrelizumab 30 mg Manufacturer: Roche Registration Gmbh